Binge-Eating Disorder (BED), distinctively outlined in the DSM-5, is characterized by unique symptoms and lack of compensatory behaviors. This sets it apart from Bulimia and Anorexia Nervosa. Understanding BED’s specific characteristics, such as recurrent binge eating without subsequent purging, is essential for accurate diagnosis and treatment. Contact Admissions for help
Understanding Bulimia Nervosa through accurate information and research is essential for creating support for those who are struggling with this disorder. It’s important to approach those affected with empathy and to encourage professional treatment. Substance abuse is notably higher among individuals with Bulimia Nervosa compared to the general population, highlighting
Anorexia Nervosa is a disorder that far exceeds simple dietary preference. This disorder reflects deep psychological distress and carries grave physical risks, including malnutrition and organ damage. Early engagement with healthcare professionals is essential for devising a comprehensive treatment strategy, integrating nutritional rehabilitation and psychological support, to combat this life-threatening
Avoidant / Restrictive Food Intake Disorder (ARFID) is distinct from other eating disorders, marked by food intake avoidance not linked to body image concerns but driven by lack of interest, sensory aversions, or fear of adverse effects. ARFID is primarily about the act of eating itself and does not involve
The link between PTSD and addiction demands an integrated, compassionate approach to treatment. Highlighting the need for early intervention and specialized care, this relationship underscores the importance of addressing both trauma and substance use to foster recovery and improve quality of life. Contact Admissions for help Contents by Sub Topic
The prevalence of Insomnia Disorder among individuals with substance abuse is notably high, with rates varying depending on the substance in question. Insomnia can be both a precursor and a consequence of substance abuse, necessitating a holistic approach to address the underlying causes and contributing factors of both conditions. Contact
I’ve witnessed firsthand the complex challenges these clients and their families face. Dual diagnosis, a term for those who struggle with both mental health disorders and substance abuse, requires an approach that is both comprehensive and tailored to individual needs.
The DSM-5 classifies Hypersomnolence Disorder as a significant sleep disorder characterized by excessive daytime sleepiness (EDS) not accounted for by insufficient sleep. This condition involves recurrent episodes of sleep or lapses into sleep within the same day, prolonged main sleep episodes of more than 9 hours that are non-restorative (unrefreshing),
The DSM-5’s classification of Bipolar I Disorder highlights its complexity, characterized by intense manic episodes and often severe depressive episodes. Distinguishing Bipolar I from Bipolar II is crucial for effective treatment, given Bipolar I’s hallmark manic episodes. Contact Admissions for help Contents by Sub Topic Substance & Medication-Induced Bipolar and
Understanding the intricate relationship between Cyclothymic Disorder and substance abuse is crucial for effective treatment. Individuals with this mood disorder may turn to substances like alcohol, cannabis, and stimulants as a coping mechanism, inadvertently exacerbating their symptoms. Contact Admissions for help Contents by Sub Topic Cyclothymic Disorder: A DSM-5 Overview
Creating a Life of Excellence Beyond Sobriety
- Since 1999 -
Disclaimer: Burning Tree Ranch aims to enhance the quality of life for individuals battling substance use and mental health disorders through well-researched and professionally reviewed content. Our publications focus on the nature of behavioral health conditions, available treatments, and their outcomes. Reviewed by licensed experts, our material is informative but not a replacement for professional advice, diagnosis, or treatment. Always seek the guidance of a licensed health provider for any medical or clinical concerns.
